These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7195856)

  • 1. [Phenylalanine level in the serum of heterozygotes for phenylketonuria under intensified protein catabolism].
    Bliumina MG
    Genetika; 1981; 17(5):910-4. PubMed ID: 7195856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria.
    Hennermann JB; Loui A; Weber A; Mönch E
    J Perinat Med; 2004; 32(4):383-5. PubMed ID: 15346830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygote detection in phenylketonuria.
    Güttler F; Hansen G
    Clin Genet; 1977 Feb; 11(2):137-46. PubMed ID: 837563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the phenylalanine tolerance test in detection of heterozygote carriers of phenylketonuria gene].
    Bernat K
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):219-21. PubMed ID: 1437822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution to the problems of determining heterozygotes in phenylketonuria by the biochemical and electroencephalographic method.
    Cechák P; Rákosníková M
    Acta Univ Carol Med Monogr; 1977; (79 Pt 3):57-64. PubMed ID: 615484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous loading of L-phenylalanine: detection of heterozygotes in phenylketonuria].
    Lambert J; Viailhet M; Monot C; Lepoire E; Baradel J; Nabet P; Martin J; Pierson M
    C R Seances Soc Biol Fil; 1973; 167(3):502-8. PubMed ID: 4785089
    [No Abstract]   [Full Text] [Related]  

  • 7. [Detection of heterozygotes of typical phenylketonuria].
    Farriaux JP; Delabre M
    Arch Fr Pediatr; 1972 Apr; 29(4):365-72. PubMed ID: 5053206
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fetal brain damage in maternal heterozygous phenylketonuria].
    Kutter D; Humbel R; Metz H
    Med Klin; 1970 Apr; 65(14):653-6. PubMed ID: 5507797
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria.
    Ponzone A; Spada M; Roasio L; Porta F; Mussa A; Ferraris S
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):561-9. PubMed ID: 18493213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early blood sampling in neonatal programs for the detection of phenylketonuria.
    Szeinberg A; Cohen BE
    Padiatr Padol; 1982; 17(2):287-92. PubMed ID: 7099682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperphenylalaninemia induced by trimethoprim-sulfamethoxazole in an infant heterozygous for phenylketonuria].
    Goutet JM; Aymard P; Leroy D; Polonovski C; Navarro J
    Nouv Presse Med; 1979 Dec; 8(49):4045-6. PubMed ID: 534266
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between the severity of brain damage in phenylketonuria and the degree of hyperphenylalaninemia].
    Bliumina MG; Lebedev BV; Kopylova NV; Sitnichenko EI; Gerasimova NS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(12):1778-81. PubMed ID: 7223198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygotes in hyperphenylalaninaemia.
    Bartholomé K; Olek K; Trefz F
    Hum Genet; 1984; 65(4):405-6. PubMed ID: 6693130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heterozygote identification in phenylketonuria].
    Rampini S; Anders PW; Curtius HC; Marthaler T
    Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1968; 43(3-4):suppl 102-3. PubMed ID: 5761621
    [No Abstract]   [Full Text] [Related]  

  • 15. Intracellular phenylalanine and tyrosine concentration in homozygotes and heterozygotes for phenylketonuria (PKU) and hyperphenylalaninemia compared with normals.
    Thalhammer O; Lubec G; Königshofer H; Scheibenreiter S; Coradello H
    Hum Genet; 1982; 60(4):320-1. PubMed ID: 7106768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria.
    Caballero B; Mahon BE; Rohr FJ; Levy HL; Wurtman RJ
    J Pediatr; 1986 Oct; 109(4):668-71. PubMed ID: 3761084
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population.
    Eisensmith RC; Martinez DR; Kuzmin AI; Goltsov AA; Brown A; Singh R; Elsas LJ II; Woo SL
    Pediatrics; 1996 Apr; 97(4):512-6. PubMed ID: 8632937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Method of detection of heterozygotic carrier state in phenylketonuria].
    Baikov AD; Sitnichenko EI
    Lab Delo; 1973; 5():293-5. PubMed ID: 4129158
    [No Abstract]   [Full Text] [Related]  

  • 19. Discrimination of heterozygotes for phenylketonuria, persistent hyperphenylalaninemia and controls by phenylalanine loading.
    Blitzer MG; Bailey-Wilson JE; Shapira E
    Clin Chim Acta; 1986 Dec; 161(3):347-52. PubMed ID: 3802540
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.
    Westwood A; Raine DN
    J Med Genet; 1975 Dec; 12(4):327-33. PubMed ID: 1219115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.